CNS Pharmaceuticals, Inc. (CNSP) Operating income 2018–2025
CNS Pharmaceuticals, Inc. (CNSP) annual operating income history from SEC filings — each fiscal year as reported.
-$16.0MFY2025 · since FY2018: -$881,787 → -$16.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.0M | -7.3% |
| FY2024 | -$14.9M | +21.0% |
| FY2023 | -$18.9M | -23.6% |
| FY2022 | -$15.3M | -5.4% |
| FY2021 | -$14.5M | -53.2% |
| FY2020 | -$9.5M | -146.7% |
| FY2019 | -$3.8M | -334.7% |
| FY2018 | -$881,787 | — |
Source: SEC XBRL filings · For reference only · Not investment advice